- authorisedTherapeutic use (Phase IV)
Impact of treatment with TransCon PTH on Quality of Life, cognitive function, brain structure, and cerebral capillary bloodflow in patients with hypoparathyroidism
This study looks at how a new treatment for hypoparathyroidism, called Yorvipath, affects memory, brain health, and blood flow in the brain. It compares it to standard treatments to see if it improves how people feel and think.
Denmark - active not recruiting
A Registry for Participants With Chronic Hypoparathyroidism
This study looks at the long-term safety and how well a treatment called rhPTH(1-84) works for chronic hypoparathyroidism. It's for people of all ages who have had the condition for at least six months and are already receiving a treatment.
United States · Austria · Canada